Roflumilast + Dual Strong Cyp3a4 Moderate Cyp1a2 Inducers Interaction
Moderateinteraction on record
Description
Co-administration may increase roflumilast systemic exposure and may result in increased adverse reactions. Weigh potential for increased adverse reactions against benefit.
Mechanism
CYP3A4 and CYP1A2 inhibition
Source: NLP:roflumilast